The Skin Cancer Education and Research Foundation – Home › Forums › Immunotherapy › Side-effect management › ASCO/NCCN guidlines now out › Reply To: ASCO/NCCN guidlines now out
I have not had a chance to review these in detail, but plan to do so as well very soon. I’m a little bit concerned about the “blanket” statements of treating based on the grade only. I’m not sure that we’ve come much further then what the drug companies provided as overall guidance early on and that concerns me for folks in the community who are not used to treating a great number of patients. I agree our care step pathways offer a more in depth set of guidelines for nurses.